Casdin Capital invests in all aspects of the life sciences revolution, partnering with companies across Healthcare, Biotechnology, Synthetic Biology, and Technology. Their investment strategy focuses on big markets, great ideas, strong teams, and a long-term perspective. They aim to create value and open new opportunities through patience and strong relationships.

Xeraya Capital is a venture capital and private equity firm focusing on life sciences investments globally, with a commitment to driving local value. They partner with innovative companies, providing venture funding or growth equity and actively supporting their growth.

UNITY VENTURES, founded in 2011, is a leading early-stage venture capital firm in China. They focus on investing in startups across various sectors, including emerging technologies and enterprise services, aiming to support the digital transformation in China.

Foresite Capital is a multi-stage healthcare and life sciences investment firm. They use a data science-driven approach to invest in companies leveraging biology and big data to transform healthcare, focusing on opportunities at the intersection of tech and biotech.

Better Ventures is a mission-driven venture capital firm investing in technology companies building a better world. They focus on B2B solutions leveraging AI/ML, software, materials science, and biotechnology, prioritizing companies addressing the UN's Sustainable Development Goals.

Green Park & Golf Ventures is a venture capital firm focused on early-stage investments in medical-related startups. They leverage the extensive operational and financial experience of their founding partners to provide strategic solutions and a strong network to their portfolio companies. Their investments typically range from $500,000 to $2,000,000.

Longwood creates and invests in science-based companies that develop novel solutions for important medical problems.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation. It invests in pioneering science with the potential for significant patient benefit, focusing on areas like immunology, regenerative medicine, and digital health. The fund provides financial support and strategic guidance to portfolio companies.

Amiti Ventures is a leading deep tech seed-stage VC firm based in Israel. They invest in transformational technologies, focusing on areas where they anticipate major shifts driven by innovation. Amiti partners with founders, providing strategic guidance and support throughout their growth journey.

Hummingbird is a global generalist seed investment fund, investing in outlier founders at the earliest stage of their journey. They partner very early and support companies throughout their lifecycle, providing patient and long-term capital.

Kurma Partners is a major player in funding healthcare and biotechnology in Europe. They work closely with research teams to create and support high-tech companies, providing capital and expertise. Kurma Partners has a strong network of partners and is committed to sustainable development and ESG practices.

M Ventures is the corporate venture capital arm of Merck, investing in early-stage biotechnology and technology companies.